Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study
In irP patients treated with 6-week prednisolone tapering therapy, OP pattern and duration to irP onset ≥ 100 days were associated with relapse risk. Assessment of the risk factors for irP relapse will be helpful for irP management.
Authors
- Satoshi Goshima (ORCID: https://orcid.org/0000-0002-1897-5709)
- Hironao Hozumi (ORCID: https://orcid.org/0000-0001-5439-1543)
- Naoki Inui (ORCID: https://orcid.org/0000-0002-4624-7119)
- Shintaro Ichikawa (ORCID: https://orcid.org/0000-0001-8043-8472)
- Mikio Toyoshima (ORCID: https://orcid.org/0000-0002-8349-0142)
- Kazuhiro Asada
- Fujisawa Tomoyuki
- Masato Karayama (ORCID: https://orcid.org/0000-0003-0455-4070)
- Yusuke Kaida (ORCID: https://orcid.org/0000-0003-3991-083X)
- Yuzo Suzuki (ORCID: https://orcid.org/0000-0001-6154-9791)
- Noriyuki Enomoto (ORCID: https://orcid.org/0000-0003-3187-4264)
- Masaki Ikeda (ORCID: https://orcid.org/0000-0003-3861-4246)
- Kazuki Furuhashi (ORCID: https://orcid.org/0000-0003-4079-5509)
- Nao Inami
- Hideki Yasui (ORCID: https://orcid.org/0000-0002-7134-3364)
- Koji Nishimoto (ORCID: https://orcid.org/0000-0002-6515-4276)
- Shun Matsuura (ORCID: https://orcid.org/0000-0001-8844-6100)
- Satoshi Funayama (ORCID: https://orcid.org/0000-0002-8915-6022)
- Hiroyuki Matsuda (ORCID: https://orcid.org/0000-0003-2323-0661)
- Dai Hashimoto
- Takashi Matsui (ORCID: https://orcid.org/0000-0001-9442-9649)
- Takafumi Suda (ORCID: https://orcid.org/0000-0001-5300-0504)
- Masato Fujii
- Yusuke Inoue
Institutions
- Hamamatsu University School of Medicine (JP)
- Seirei Mikatabara General Hospital (JP)
- Shizuoka City Shimizu Hospital (JP)
- Iwata City Hospital (JP)
- Shizuoka Saiseikai General Hospital (JP)
- Hamamatsu Rosai Hospital (JP)
- Seirei Hamamatsu General Hospital (JP)
- Shizuoka City Hospital (JP)
- Shizuoka General Hospital (JP)
- Shizuoka Red Cross Hospital (JP)
- Fujieda Municipal General Hospital (JP)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1186/s12890-024-03284-3
- Citations
- 5
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.41